SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 1.0700.0%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Jagow who wrote (10002)8/16/1998 11:36:00 AM
From: Scott H. Davis   of 14328
 
I've posted tax loss selling concerns, but looking at how well TRIBY has held up recently, plus the fact that now we are not looking at a year of big gains to be offset, plus biotech investors are porbably looking a some with much bigger losses means the tax loss selling this year may not be nearly a significant applied to TRIBY.

If the EPS next qtr shows material improvement (no excuses for this one - the moving expenses are over, shares issued for prior acquisitions are already factored in) with out additional shares, TRIBY can indeed escape the tax pull. Especially if they can couple this with good news on the FDA front. IMSCO Scott
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext